Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +55.52%
#3 Glidr Glidr +38.71%
#4 Cysic Cysic +28.33%
#5 Walrus Walrus +25.77%
#6 Humanity Humanity +25.08%
#7 Enso Enso +18.12%
#8 Velvet Velvet +16.00%
#9 Tutorial Tutorial +15.35%
#10 OVERTAKE OVERTAKE +15.31%
Coin of the day
EXOD EXOD
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Quantum Genomics S.A. Quantum Genomics S.A.

Quantum Genomics S.A.

ALQGC
Classement en actions #37063
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France,... Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
Prix de l'action
$0.07600875
Dernière synchronisation: 2024-11-20
Capitalisation boursière
$2.06M
Changement (1 jour)
-0.51%
Changement (1 an)
0.00%
Pays
FR
Échange Quantum Genomics S.A. (ALQGC)

Catégorie

Healthcare
Nombre d'actions en circulation pour Quantum Genomics S.A. (ALQGC)
Nombre d'actions en circulation au December 2024: 69.71M
Selon les derniers rapports financiers et le cours de l'action de Quantum Genomics S.A., le nombre actuel d'actions en circulation est de 69.71M. À la fin de December 2023, l'entreprise avait 34.86M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Quantum Genomics S.A. (ALQGC) de 2009 à 2026
Actions en circulation à la fin de chaque année
Année Actions en circulation Changez
2026 (TTM) 69.71M 0.01%
2024 69.71M 99.98%
2023 34.86M 0.96%
2022 34.53M 28.05%
2021 26.96M 32.10%
2020 20.41M 13.53%
2019 17.98M 14.39%
2018 15.72M 43.77%
2017 10.93M 30.86%
2016 8.35M 20.85%
2015 6.91M 43.72%
2014 4.81M 16.49%
2013 4.13M 84.23%
2012 2.24M 877.02%
2011 229.39K 0.00%
2010 229.39K 0.00%
2009 229.39K 0.00%
Actions en circulation pour des entreprises similaires ou concurrentes
Entreprise Actions en circulation Différence Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 264.21%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -10.80%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE